Welcome : Guest

AEterna Zentaris, Inc. (Canada) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about AEterna Zentaris, Inc., which is principally involved in Biopharmaceuticals Business. Illustrated with 68 tables, the report showcases the company's recent news stories and events, sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-10266
Price: $3400
Company Type: Public
Pages: 70
Date: November 2016
Market Data Tables: 68

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Aeterna Zentaris, Inc.'s Sales by Geographic Region Worldwide (2015) in US$ Thousands for United States, Switzerland, Japan, China, and Others......2
Biopharmaceuticals......3
Table 2: Biopharmaceuticals Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Norditropin, NovoSeven, Turoctocog Alpha, and Others......3
Cancer Drugs......4
Table 3: Oncology/Hematology Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Blood Cell Factors, Chemopreventatives, Chemotherapeutics, Mabs, Targeted Therapies, and Others......4
Table 4: Oncology Drug Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for European Union Five, Japan, US and Others......5
Cancer Market......6
Table 5: Cancer Care Expenditure by Site Worldwide (2015) - Percentage Share Breakdown for Breast, Colorectal, Lymphoma, Lung, Prostate and Others......6
Table 6: Cancer Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Heme, Lung, Prostate, and Others......7
Table 7: Oncology Market by Cancer Type Worldwide (2015) - Percentage Share Breakdown by Value for Breast Cancer, Metastatic Colorectal Cancer, Non-Small Cell Lung Cancer, and Others......8
Table 8: Clinical Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......9
Table 9: Hereditary Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......10
Table 10: Cancer Market by Type in China (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Esophagus, Liver, Lung, Stomach and Others......11
Table 11: Oncology Market by Category in China (2015) - Percentage Share Breakdown by Value for Anti- Tumor Agents, Hormone Therapy, Immuno Suppresants and Immunostimulants......12
Table 12: Oncology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Solid Tumor and Others......13
Cancer Patients......14
Table 13: Breast Cancer Diagnoses by Hospital Type in the US (2015) - Percentage Share Breakdown by Volume for Community, Comprehensive, Teaching and Research, and Others......14
Table 14: No. of Colorectal Cancer Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......15
Table 15: No. of Invasive Breast Cancer Patients by Category Worldwide (2015) - Percentage Market Share Breakdown for Stage I and Stage II-III......16
Table 16: No. of Primary Liver Cancer Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......17
Table 17: No. of Chronic Lymphocytic Leukemia (CLL) (1L) Patients by Category Worldwide (2015) - Percentage Market Share Breakdown for Imbruvica PCYC, Rituxan, Gazyva ROG, and Others......18
Table 18: No. of Cutaneous Melanoma Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......19
Table 19: No. of Ocular Melanoma Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......20
Table 20: Female Mortality by Cancer Type in China (2015) - Percentage Market Share Breakdown by Volume for Lung, Breast, Colon, Rectum and Anus, Intestine, Liver, and Others......21
Table 21: Male Mortality by Cancer Type in China (2015) - Percentage Market Share Breakdown by Volume for Colon, Colon, Rectum and Anus, Intestine, Liver, Lung, and Others......22
Table 22: No. of Chronic Lymphocytic Leukemia (CLL) (1L) Patients by Category in European Union (2015) - Percentage Market Share Breakdown for Rituxan, Gazyva, and Others......23
Table 23: No. of Chronic Lymphocytic Leukemia (CLL) (R/R) Patients by Category in European Union (2015) - Percentage Market Share Breakdown for Rituxan, Gazyva, and Others......24
Table 24: No. of Cancer Patients by Type in the US (2015) - Percentage Market Share Breakdown for Colorectal Cancer (CRC), Melanoma, Non-Squamous Non-Small-Cell Lung Cancer (NSCLC), Ovarian, Prostate, Renal Cell Carcinoma (RCC), and Squamous Non-Small-Cell Lung Cancer (NSCLC)......25
Table 25: Number of Cancer Patients by Type in the US (2015) - Percentage Share Breakdown by Volume for Bladder Cancer, Breast Cancer (Female), Colon and Rectum Cancer, Endometrial Cancer, Kidney and Renal Pelvis Cancer, Lung and Bronchus Cancer, Melanoma of the Skin, Non-Hodgkin Lymphoma, Prostate Cancer, and Thyroid Cancer......26
Table 26: No. of Cancer Patients Death by Type in the US (2015) - Percentage Share Breakdown for Breast, Colorectal, Lung, Melanoma, and Prostate......27
Table 27: New Patients with Cancer by Site in the US (2015) - Percentage Market Share Breakdown by volume for Colorectal, Lung and Bronchus, Melanoma, Pancreas, and Others......28
Table 28: Number of Cancer Patients by Type Worldwide (2015) - Percentage Share Breakdown by Volume for Bladder, Breast, Cervix Uteri, Colorectum, Liver, Lung, Non-Hodgkin lymphoma, Oesophagus, Prostate, and Stomach......29
Table 29: No. of Bladder Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Invasive Patients, and Non-Invasive Patients......30
Table 30: No. of Invasive Breast Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Stage I and Stage II-III......31
Table 31: New Patients with Cancer in Stage 3/4 by Site in the US (2015) - Percentage Market Share Breakdown by Volume for Colorectal, Lung and Bronchus, Pancreas and Others......32
Table 32: No. of Solid Cancer Tumor Patients by Type Worldwide (2015) - Percentage Share Breakdown for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......33
Table 33: No. of Non Small Cell Lung Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Stage I, Stage II-III, Stage III-IV, and Undiagnozed......34
Cervical Cancer......35
Table 34: Cervical Cancer Market by HPV Type in England (2015) - Percentage Share Breakdown by Value for HPV 16, HPV 18, HPV 33, HPV 45, and Others......35
Table 35: Cervical Cancer Market by HPV Type in Europe (2015) - Percentage Share Breakdown by Value for HPV 16, HPV 18, HPV 31, HPV 33, and Others......36
Hematological Cancer......37
Table 36: Hematological Cancer by Category Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM), and Non-Hodgkin’s Lymphoma (NHL)......37
Skin Cancer......38
Table 37: Skin Cancer by Type Worldwide (2015) - Percentage Market Share Breakdown by Volume for Basal Cell Carcinomas, Melanoma, and Squamous Cell Carcinomas......38
Cancer-Associated Mucositis......39
Table 38: Cancer-Associated Mucositis Market by Activity Worldwide (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Head and Neck, Non-Small Cell Lung cancer and Others......39
Chronic Myelogenous Leukemia (CML)......40
Table 39: Chronic Myelogenous Leukemia (CML) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for Asia-Pacific, Canada, European Union, Japan, USA, and Others......40
Multiple Myeloma......41
Table 40: Multiple Myeloma by Age Group Worldwide (2015) - Percentage Share Breakdown by No. of New Cases for 45-54, 55-64, 65-74, 75-84, >84, and Others......41
Table 41: Multiple Myeloma Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Kyprolis AMGN, Pomalyst CELG, Revlimid CELG, Thalomid CELG, and Velcade TKD/JNJ......42
Hormone Therapy......43
Table 42: Hormone Therapy Treatment Market by Specialist Type Worldwide (2015) - Percentage Share Breakdown by Value for Oncologists, Urologists and Others......43
Table 43: Female Hormone Treatment Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for Hormone Replacement Therapy and Others......44
Table 44: Female Hormone Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for Estrogen, Hormone Replacement Therapy and Vegetable Female Hormone......45
Table 45: Female Hormone Treatment Market by Product in Korea (2015) - Percentage Share Breakdown by Value for Natural Estrogen Therapy and Others......46
Growth Hormones......47
Table 46: Growth Hormone Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, Japan and United States......47
Table 47: Growth Hormone Market by Growth Disorder Indication in Europe (2015) - Percentage Share Breakdown by Value for Adult Growth Hormone Deficiency (GHD), Pediatric Growth Hormone Deficiency (GHD), Turner Syndrome and Others......48
Table 48: Growth Hormone Market by Growth Disorder Indication in Japan (2015) - Percentage Share Breakdown by Value for Pediatric Growth Hormone Deficiency (GHD) and Turner Syndrome......49
Table 49: Growth Hormone Market by Growth Disorder Indication in the US (2015) - Percentage Share Breakdown by Value for Adult Growth Hormone Deficiency (GHD), Idiopathic Short Stature (ISS), Pediatric Growth Hormone Deficiency (GHD), Turner Syndrome and Others......50
Human Growth Hormones (hGH)......51
Table 50: Human Growth Hormone (hGH) Market by Growth Disorder Indication Worldwide (2015) - Percentage Share Breakdown by Value for Idiopathic Short Stature, Pediatric Growth Disorder Deficiency (GHD), Turner Syndrome and Others......51
Table 51: Human Growth Hormone Sales by Product in the US (2015) - Percentage Share Breakdown by Value for Genotropin (Pfizer), Humatrope (Eli Lilly), Norditropin (Novo Nordisk), Nutropin (Roche), Saizen, serostim (Merck KGaA) and Others......52
Pediatric Growth Hormone Deficiency (GHD)......53
Table 52: Pediatric Growth Hormone Deficiency (GHD) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, Japan and United States......53
Table 53: Pediatric Growth Hormone Deficiency (GHD) Market by Product in the US (2015) - Percentage Share Breakdown by Value Genotropin, Humatrope, Norditropin and FlexPro (NordiFlex), Nutropin AQ and Others......54
Adult Growth Hormone Deficiency (GHD)......55
Table 54: Adult Growth Hormone Deficiency (GHD) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe and United States......55
Biopharmaceuticals......56
Table 55: Market Shares of Leading Biopharmaceutical Companies Worldwide (2014) - Percentage Breakdown by Volume (Installed Capacity) for Amgen Inc., Biogen Idec, Inc., Bristol-Myers Squibb Company, C.H. Boehringer Sohn AG & Co. KG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Johnson & Johnson Ltd., Lonza Group Ltd., Pfizer, Inc., Sanofi S.A., and Others......56
Table 56: Market Shares of Leading Biopharmaceutical Companies in the US (2015) - Percentage Market Share Breakdown by Value for Actelion Pharmaceuticals Ltd., Alexion Pharmaceuticals, Inc., Celgene Corporation, Gilead Sciences, Inc., Incyte, Corporation, Isis Pharmaceuticals, Inc., Vertex Pharmaceuticals, Inc., and Others......57
Cancer Drugs......58
Table 57: Market Shares of Leading Oncology Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Fresenius SE & Co., and Others......58
Table 58: Market Shares of Leading Oncology/Hematology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......59
Table 59: Market Shares of Leading Oncology Drug Manufacturers in China (2015) - Percentage Share Breakdown by Value for Astrazeneca, Jiangsu Hengrui Medicine Co., Ltd., Roche Group and Others......60
Table 60: Anti-Cancer Drugs Market by Product Type in China (2015) - Percentage Share Breakdown by Value for Anastrozole, Capecitabine, Cetuximab, Compound kushen, Docetaxel, Epirubicin, Erlotinib, Gefitinib, Gemcitabine, Goserelin, Interferon α-2a, Interferon α-2b, Irinotecan, Kangai, Lentinan, Letrozole, Oxaliplatin, Paclitaxel, Pemetrexed, Pidotimod, RhG-CSF, RhIL-2, Rituximab, Sorafenib, Sshenqi Fuzheng, Thymopentin, Thymosin a1, Trastuzmmab, Triptorelin, TS-1, and Others......61
Table 61: Anti-Cancer Drugs Market by Type in China (2015) - Percentage Share Breakdown by Value for Alkylating Agents, Antibiotics, Antimetabolites, Hormonal Agents, Immunostimulant, Plant Alkaloids, and Others......62
Breast Cancer Drugs......63
Table 62: Market Shares of Leading Breast Cancer Drugs by Value Sales in China (2014) - Percentage Breakdown for Alkylating Agents, Antimetabolite, Antitumor Antibiotics, Antitumor Antihormone, Antitumor Botanicals, Monoclonal Antibodies, Targeted Small Molecule Agents, and Others......63
Relapsed/Refractory (RR) Chronic Lymphocytic Leukemia (CLL)......64
Table 63: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory (RR) Chronic Lymphocytic Leukemia (CLL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib, Idelalisib and Others......64
Relapsed/Refractory (RR) Indolent Non-Hodgkin's Lymphoma (iNHL)......65
Table 64: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory (RR) Indolent Non-Hodgkin's Lymphoma (iNHL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib, Idelalisib and Others......65
Table 65: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma (R/R- aNHL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib and Others......66
Human Growth Hormones (HGH)......67
Table 66: Market Shares of Leading Human Growth Hormones (HGH) Producers Worldwide (2015) - Percentage Breakdown by Value for Eli Lilly and Company (Humatrope), Merck KGaA (Saizen,Serostim), Novo Nordisk A/S (Norditropin), Pfizer Inc. (Genotropin), Roche Holding AG (Nutropin), Teva Pharmaceutical Industries Ltd. (Tev-Tropin) and Others......67
Table 67: Market Shares of Leading Growth Hormone Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Eli Lilly and Company (humatrope), Novo Nordisk (Norditropin), Pfizer, Inc. (Genotropin), Roche Holdings AG (Nutropin) and Others......68
Table 68: Market Shares of Leading Human Growth Hormones (HGH) Producers in the US (2015) - Percentage Breakdown by Value for Eli Lilly and Company, Genentech, Inc. and Roche Holding AG, Merck KGaA, Novartis International AG, Novo Nordisk A/S, Pfizer, Inc. and Teva Pharmaceutical Industries Ltd.......69